Thyme Care
Category: AI in Healthcare
An AI-powered value-based oncology care navigation platform that combines virtual care teams with proprietary technology to deliver personalized cancer care support, proactive symptom management, and comprehensive psychosocial services. Thyme Care was founded in 2020. The company is led by Robin Shah. Based in Nashville, Tennessee, USA. Team size: 500-700. Total funding raised: $275.0M. Latest round: Series D. Key investors include ["CVS Health Ventures","Humana","Morgan Health (JPMorgan Chase)","a16z Bio + Health","Foresite Capital","Concord Health Partners","Town Hall Ventures","AlleyCorp","Frist Cressey Ventures","Texas Oncology","Memorial Hermann Health System"].
- Founded
- 2020
- Headquarters
- Nashville, Tennessee, USA
- Team size
- 500-700
- Total funding
- $275.0M
Value proposition
Improves clinical outcomes while reducing total cost of care through AI-powered navigation, proactive symptom management, and comprehensive wraparound support services—demonstrating 30% relative reduction in ED/inpatient events and 20% reduction in hospital readmissions for high-risk members.
Products and solutions
["Thyme Box (AI-powered care management platform)","Thyme Care Connect (care coordination solution)","Thyme Care Signal (risk stratification and analytics)","Integrated Social Support (ISS) Model with AI Acuity Engine","Virtual Care Navigation Team (oncology-trained NPs, nurses, social workers, care partners)","Thyme Care Oncology Partners (TCOP)","Pharmacy Solutions","24/7 Virtual Urgent Care Support","Palliative Care Integration"]
Unique value
Combines AI-powered acuity engine with human virtual care teams to proactively identify and address psychosocial barriers (financial toxicity, food insecurity, transportation) in cancer patients; positions licensed clinical social workers as first-line intervention using real-time data signals rather than reactive patient reporting; integrates validated screening tools (NCCN Distress Thermometer, Columbia Suicide Risk Assessment) with dynamic patient triaging.
Target customer
Health plans and payers, risk-bearing provider organizations, self-insured employers, health systems, and senior-focused primary care organizations (e.g., CenterWell, Conviva)
Industries served
["Value-Based Oncology Care","Healthcare Navigation & Care Coordination","Digital Health & Health Tech","Population Health Management","Cancer Care Delivery","Social Determinants of Health (SDOH)"]
Technology advantage
Proprietary AI infrastructure continuously aggregates and synthesizes claims data, electronic health records, and social determinants of health indicators into a dynamic acuity model that triages patients in real-time; automates documentation and surfaces next-step guidance to reduce cognitive load on care teams; enables scaling of value-based oncology care across all 50 states with consistent quality outcomes; proven model achieving 88% member satisfaction and significant cost reductions.
How they differentiate
AI-powered oncology navigation platform with proprietary acuity engine for proactive psychosocial support, integrated virtual care teams (oncology-trained NPs, nurses, social workers), and value-based care model achieving 30% reduction in ED/inpatient events; positions licensed clinical social workers as first-line intervention using real-time data signals rather than reactive patient reporting
Main competitors
["Jasper Health","Reimagine Care","Osara Health"]
Key partnerships
["CVS Health Ventures (strategic investor)","Humana / CenterWell / Conviva (care delivery partnership across 7 states)","Morgan Health - JPMorgan Chase (strategic investor)","a16z Bio + Health (investor)","Foresite Capital (investor)","Texas Oncology (strategic partner and investor)","Memorial Hermann Health System (strategic investor)","1,000+ oncologist partners nationwide","Multiple health plans and employers across all 50 states"]
Notable customers
["Humana / CenterWell / Conviva (7-state partnership)","American Oncology Network (AON) - achieved $6M savings in EOM","Premera Blue Cross","Oak Street Health","EmblemHealth","Vytalize Health","AmeriHealth New Jersey"]
Major milestones
["Series D unicorn ($1B+ valuation) achieved in September 2025","Achieved profitability in 2025","AI-powered Integrated Social Support Model launched 2025 with 40+ licensed master-level social workers","Thyme Care Oncology Partners (TCOP) platform unveiled 2024","Named to Fierce Healthcare's Fierce 15 list (2024)","Partnership with American Oncology Network (AON) for CMS Enhancing Oncology Model (EOM)","CenterWell partnership bringing cancer support to home across 7 states (March 2026)"]
Growth metrics
270,000+ cancer patients served nationwide; 500-700 employees; $5B+ oncology spend under management; 8 million people with access; 1,000+ oncologist partners; 88% member satisfaction; 30% reduction in ED/inpatient events; 20% reduction in hospital readmissions; nearly 20% reduction in total cost of care
Market positioning
Leading value-based cancer care enabler operating as Series D unicorn ($1B+ valuation) with profitability achieved; manages $5B+ in oncology spend across all 50 states serving 270,000+ patients with 1,000+ oncologist partners
Geographic focus
United States (all 50 states nationwide)
Patents and IP
No registered patents publicly disclosed as of latest update (searches of patent databases and company disclosures did not reveal specific Thyme Care patent filings)
About Robin Shah
Co-Founder & CEO at Thyme Care (2020-Present); Co-Founder and Chief Development and Marketing Officer at OneOncology (2018-2020); VP of Provider Marketing and Strategy at Flatiron Health (2014-2018) as employee #3; Practice Administrator and Business Manager at Gettysburg Cancer Center (2009-2014).
Official website: https://www.thymecare.com